Successful Use of Difelikefalin in Severe Chronic Kidney Disease–Associated Pruritus in a Patient With Complex Etiological Contributors: A Case Report
Conclusion: In a patient with longstanding conditions and multiple comorbidities, difelikefalin showed sustained effectiveness against H1-receptor antagonist– and gabapentin–resistant CKD-aP. Difelikefalin was well tolerated over the long term.
Saved in:
| Main Authors: | Johannes M. Werzowa, Margit Hemetsberger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Case Reports in Nephrology |
| Online Access: | http://dx.doi.org/10.1155/crin/6626611 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Difelikefalin in the treatment of hemodialysis patients with pruritus: a systematic review and meta-analysis
by: Xiaoyue Cai, et al.
Published: (2024-12-01) -
Contrasting Evolution After Withdrawal of Long-Term Administration of Difelikefalin for CKD-Associated Pruritus
by: Guy Rostoker, et al.
Published: (2024-04-01) -
The efficacy and safety of difelikefalin for pruritus in hemodialysis patients: a systematic review and meta-analysis of randomized controlled trials
by: Abdallah Saeed, et al.
Published: (2024-12-01) -
Effectiveness of switching from nalfurafine to difelikefalin in patients with hemodialysis-associated pruritus: a prospective interventional study within a new treatment algorithm
by: Naoko Takahashi, et al.
Published: (2025-07-01) -
Pruritus and Atopic Dermatitis: from Etiological Features to Management
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)